ArticleOncology letters2017

Sequential administration of XELOX and XELIRI is effective, feasible and well tolerated by patients with metastatic colorectal cancer.

Taro Fukui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.